Xbrane Talks Launch Plans After Initiating US Xlucane Study

 
• By Grace Montgomery
  
Start
Xbrane has begun the clinical trial for its ranibizumab biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products